McClellan outlines FDA efforts at BIO 2003

被引：0

|

作者：

Jarvis, Lisa

机构：

来源：

Chemical Market Reporter | 2003年 / 263卷 / 26期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 50 条

[1] McClellan nominated to head FDA
Dove, A
NATURE MEDICINE, 2002, 8 (11) : 1190 - 1190
[2] McClellan nominated to head FDA
Alan Dove
Nature Medicine, 2002, 8 : 1190 - 1190
[3] BIO's departing president outlines industry's ongoing challenges: FDA, reimbursement, and ethics
Feldbaum, C
BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2004, 17 (04): : 74 - 74
[4] SURVEY OUTLINES HOSPITAL COLLABORATION EFFORTS
不详
HOSPITALS, 1993, 67 (10): : 54 - 54
[5] McClellan's FDA: boon to industry, consumers, or both?
Ault, A
LANCET, 2003, 362 (9381): : 379 - 380
[6] Pioneer McClellan's departure leaves FDA rudderless again
Butler, R
CHEMISTRY & INDUSTRY, 2004, (05) : 4 - 4
[7] FDA outlines steps for individualized drug development
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (02) : 91 - 91
[8] FDA outlines steps for individualized drug development
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 91 - 91
[9] FDA Outlines Strategy to Spur Biomedical Innovation
Ritter, Amy
BIOPHARM INTERNATIONAL, 2011, 24 (11) : 11 - 11
[10] EPA outlines new approach for upcoming enforcement efforts
Hazard Waste Consult, 1 (3.5):

← 1 2 3 4 5 →